{{ item.label }}: {{ item.title }}

Controlled Drugs: Ensuring the Safer Management, Diversion & Abuse, Prescribing and Use

Thu, 16 Oct 2025

Virtual, Online

Follow the conference on X #controlleddrugs 

“There are still risks from controlled drugs in the health and care system.”

The Safer Management of Controlled Drugs Annual Report, Care Quality Commission July 2025

“A recurrent theme is the lack of effective communication between healthcare providers and patients – both within care settings and across boundaries of care. Several deaths have been attributed to not sharing or adequately communicating information in a timely way… The failure to update and share critical medicines information across care settings is a significant risk to patient safety. Health and care systems need to ensure seamless communication and accurate record-keeping, particularly when managing controlled drugs.

The Safer Management of Controlled Drugs Annual Report, Care Quality Commission July 2025

“Our findings from both inspections and prescribing data indicate that healthcare professionals are working outside their scope of practice, and in some cases, outside of the law. To ensure people receive safe care, all healthcare professionals must work within their scope of practice.”

The Safer Management of Controlled Drugs Annual Report, Care Quality Commission July 2025

“Prescribing controlled drugs carries the risk of misuse, which puts healthcare professionals in the difficult position of determining whether a patient's request is genuine. Assuming drug-seeking behaviour without thoroughly reviewing a patient's history has resulted in serious consequences.”

The Safer Management of Controlled Drugs Annual Report, Care Quality Commission July 2025

“CQC expects that issues and concerns raised by the CDAO are discussed at board level and that these will be prioritised and scrutinised as appropriate for the specific circumstances.”

The Safer Management of Controlled Drugs Annual Report, Care Quality Commission July 2024

“We know that these incidents are not always reported to us, and we encourage services to report any instances associated with controlled drugs that meet these thresholds to us as soon as possible.”

The Safer Management of Controlled Drugs Annual Report, Care Quality Commission July 2025

“Good governance is central to the safe and effective management of controlled drugs… Make sure your governance processes are up-to-date and fit for purpose.”

The Safer Management of Controlled Drugs, Care Quality Commission

“We often hear that CDAOs are not resourced effectively.”

The Safer Management of Controlled Drugs Annual Report, Care Quality Commission July 2025

“Key issues discussed at local intelligence network meetings include Diversion of controlled drugs: - by health and care professionals and support staff - in the lower schedules - through using electronic systems to conceal the theft. ”

The Safer Management of Controlled Drugs Annual Report, Care Quality Commission July 2025

The National Controlled Drugs Virtual Conference focuses ensuring the Safer Management of Controlled Drugs: Diversion & Abuse, Prescribing and Use. Aimed at Controlled Drugs Accountable Officers, Pharmacists, Police Controlled Drugs Liaison Officers, and Prescribers including Non Medical Prescribers, the conference will update you on current national developments, developing the role of the CDAO and improve practice learning from case studies. There is also new sessions focusing on a case study on accounting for losses on a hospitals ward, and a Coroner Perspective; learning from the Coroner and Prevention of Future Deaths reports following the 2025 CQC findings.

This conference will enable you to:

  • Network with colleagues who are working to improve the safe use, prescribing and management of controlled drugs

  • Understand the national context including developments from the CQC

  • Assess practice against the RPS Standards for the governance and management of Controlled Drugs

  • Understand the scale of abuse and diversion of controlled drugs by healthcare professionals

  • Ensure effective Controlled Drugs Governance and learning from audit

  • Improve your skills in the identification and management of theft and abuse by staff

  • Learn from police investigations and inspections

  • Learning from Syringe Driver related controlled drugs incidents

  • Understand and develop the role of the controlled drugs accountable officer

  • Improve your skills in the prescribing and prescribing governance of controlled drugs the Non Medical Prescriber and controlled drugs

  • Reflect on the use and governance of controlled drugs at the end of life

  • Update your knowledge on learning from deaths involving controlled drugs, and using the Coroner Future of Deaths report to inform changes in practice

  • Improve practice in governance and prescribing of opioids

  • Reflect on a case study investigation and learning from losses on a hospital ward

  • Ensure lessons are learned from the investigation and reporting of controlled drugs incidents

  • Self assess and reflect on your own practice

  • Supports CPD professional development and acts as revalidation evidence. This course provides 5 Hrs training for CPD subject to peer group approval for revalidation purposes

Speakers include:

Dr Weeliat Chong

Chief Pharmacist
Pharmacy
Humber Teaching NHS Foundation Trust

Kandarp Thakkar

Chief Pharmacist, Clinical Director of Medicines Optimisation & Controlled Drugs Accountable Officer
University Hospitals Plymouth NHS Trust

Wendy Mcallister

Controlled Drugs Security Consultant
Babcocks International Ltd

Ms Sandra Campbell

Independent Nurse Consultant
Lead Cancer Team
Scottish Ambulance Service

Exhibition & Sponsorship Packages

This conference offers a valuable opportunity for industry suppliers to personally meet with their target audience where they will have time to talk and demonstrate the benefits of their products. High quality specialist audiences make having a presence at our events a highly targeted and cost effective marketing channel.

Why Exhibit?

Having a presence at this event will give you the opportunity to:

  • Demonstrate your product, system or service
  • Network and engage with your key audience  
  • Generate new business leads
  • Gain exposure for your brand and raise the profile of your organisation
  • Understand the current needs of your audience and challenges they’re facing
  • Update your knowledge of national policy and local developments  

Enquire

Contact Sarah Jane for exhibition and sponsorship prices, or to discuss a tailored package to suit your needs and budget.

Fee Options

Virtual NHS, Schools, Care and Public Sector

£295.00

(£354.00)

Virtual Voluntary sector & charities

£250.00

(£300.00)

Virtual Commercial organisations

£495.00

(£594.00)

(Prices in brackets include VAT)

Discounts

Additional delegate discount:

A discount of 15% will be applied to fees for any extra delegates.

Online discount:

A discount of 10% will be applied if you pay using the website.

Also of Interest

Supporting Organisations

Browser unsupported

You’re using an unsupported browser.

This website uses the latest web technology and your browser doesn't support those technologies at this time.

Please update to Chrome, Firefox, Edge or Safari (on Mac) to view the full experience.